Apogee Therapeutics, Inc. APGE Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Apogee Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s free cash flow yield?
- Apogee Therapeutics, Inc. (APGE) reported free cash flow yield of -4.5% in Q4 2025.
- How has Apogee Therapeutics, Inc.'s free cash flow yield changed year-over-year?
- Apogee Therapeutics, Inc.'s free cash flow yield increased by 32.5% year-over-year, from -6.7% to -4.5%.
- What is the long-term trend for Apogee Therapeutics, Inc.'s free cash flow yield?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s free cash flow yield has grown at a -10.1% compound annual growth rate (CAGR), from -5.6% to -4.5%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.